Fingerprint
Dive into the research topics of 'High-dose oral ziprasidone versus conventional dosing in schizophrenia patients with residual symptoms: The ZEBRAS study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
High-dose oral ziprasidone versus conventional dosing in schizophrenia patients with residual symptoms: The ZEBRAS study
Donald C. Goff, Joseph P. McEvoy, Leslie Citrome, Arnold W. Mech, Juan R. Bustillo, Roberto Gil, Peter Buckley, Theo C. Manschreck, Eric D. Achtyes, Eric A. Macklin
Research output: Contribution to journal › Article › peer-review
15
Scopus
citations